Vascular Dementia

Vascular Dementia refers to the decline in thinking ability caused by cerebrovascular diseases. Discover the latest research on aspects underlying vascular dementia here.

October 16, 2021
Case Report

Hereditary cerebral amyloid angiopathy mimicking CADASIL syndrome.

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Klearchos PsychogiosGeorgios Tsivgoulis
October 16, 2021
Open Access

Neurofilament light: a possible prognostic biomarker for treatment of vascular contributions to cognitive impairment and dementia.

Journal of Neuroinflammation
Christina Hoyer-KimuraMeredith Hay
October 15, 2021

Traumatic brain injuries among veterans and the risk of incident dementia: A systematic review & meta-analysis.

Age and Ageing
Karen K LeungJean A C Triscott
October 15, 2021
Open Access

Increased Levels of Circulating Angiogenic Cells and Signaling Proteins in Older Adults With Cerebral Small Vessel Disease.

Frontiers in Aging Neuroscience
Arunima KapoorDaniel A Nation
October 15, 2021
Review

Brain energy failure in dementia syndromes: Opportunities and challenges for glucagon-like peptide-1 receptor agonists.

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Hussein N YassineKonrad Talbot
October 14, 2021

Dementia risk among Mongolian population with type 2 diabetes: a matched case-control study.

Journal of Integrative Neuroscience
Munkh-Undral MunkhsukhOyuntugs Byambasukh
October 13, 2021
Open Access

First delirium episode in Parkinson's disease and parkinsonism: incidence, predictors, and outcomes.

NPJ Parkinson's Disease
Samantha GreenAngus D Macleod
October 12, 2021

Thyroid status and brain circulation: The Rotterdam Study.

The Journal of Clinical Endocrinology and Metabolism
Lana FaniLayal Chaker
October 12, 2021
Review

PM2.5 exposure in association with AD-related neuropathology and cognitive outcomes.

Environmental Pollution
Kitti ThiankhawSiriporn C Chattipakorn
October 11, 2021

Observational Extension of the Prevention of Dementia by Intensive Vascular Care (preDIVA) Trial.

JAMA Neurology
Marieke P Hoevenaar-BlomWim A van Gool
October 11, 2021

Investigating Predictors of Preserved Cognitive Function in Older Women Using Machine Learning: Women's Health Initiative Memory Study.

Journal of Alzheimer's Disease : JAD
Ramon CasanovaStephen R Rapp
October 11, 2021
Open Access

An ALE Meta-Analysis of Specific Functional MRI Studies on Subcortical Vascular Cognitive Impairment.

Frontiers in Neurology
Wenwen XuJiu Chen
October 9, 2021

Whole-exome sequencing reveals a role of HTRA1 and EGFL8 in brain white matter hyperintensities.

Brain : a Journal of Neurology
Rainer MalikMartin Dichgans
October 8, 2021
Review

Small Vessel Disease, a Marker of Brain Health: What the Radiologist Needs to Know.

AJNR. American Journal of Neuroradiology
A MahammediA Vagal

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

ATG proteins

The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes.

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.

© 2021 Meta ULC. All rights reserved
/feed-previews/vascular-dementia/61137a20-82ff-4ffe-b807-bc3f4e595435